Kardigan
Business Services · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
506 Carnegie Center Dr Ste 201, Princeto...Phone Number
(415) 573-3220Website
kardigan.bioRevenue
-Industry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
2
About Kardigan
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve.Explore more
Kardigan Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kardigan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Kardigan launches new products
Congratulate Masked Content for being promoted to Masked Content at Kardigan
Funding: Get notified immidiatlly once Kardigan has new funding data
Click to see if Kardigan had a recent Job posting/layoffs
Earning: See what the market has to say on Kardigan recently announced quarterly report
Kardigan, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Kardigan is spiking on competitors!
Check if Kardigan has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Kardigan is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kardigan is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kardigan.
Kardigan financials insights
Gather financial insights about Kardigan, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$300M
Series B
$254M
Kardigan Tech Stack
A closer look at the technologies used by Kardigan
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Kardigan News & Media
Heart drug biotech Kardigan raises $400m in upscaled IPO - pharmaphorum
Cardiovascular drug developer Kardigan has completed its IPO, raising substantially more than it originally anticipated.Office updates: Kardigan inks Princeton lease following $300M raise - NJBIZ
JLL helped the biopharma secure space to establish its East Coast presence, one of several recent transactions in the sector bringing tenants to Monmouth, Somerset and Morris counties.Kardigan Acquires Prolaio
Kardigan, a San Francisco, CA- and Princeton, NJ-based health company modernizing cardiovascular (CV) drug development, acquired Prolaio, a Chicago, IL-based clinical intelligence company advancing cardiology research and care with real-world patient data and insights. The amount of the deal was not disclosed. With the acquisition, Kardigan will gain access to Prolaio’s CV data collection and analytics […] The post Kardigan Acquires Prolaio appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kardigan
Sign Up For FreeTo access detailed company insights
Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the und... Read More
